Insulin Glargine Plus Insulin Glulisine MDI Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) Evaluating Differences in Patient Reported Outcomes.
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2010
At a glance
- Drugs Insulin aspart/insulin protamine aspart; Insulin glargine; Insulin glulisine; Insulin neutral protamine lispro/insulin lispro
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 29 Jun 2010 Results have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 26 Jun 2010 Results reported in two abstracts at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA), according to a sanofi aventis media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History